High fractional excretion of glycation adducts is associated with subsequent early decline in renal function in type 1 diabetes

Abstract Increased protein glycation, oxidation and nitration is linked to the development of diabetic nephropathy. We reported levels of serum protein glycation, oxidation and nitration and related hydrolysis products, glycation, oxidation and nitration free adducts in patients with type 1 diabetes...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Bruce A. Perkins, Naila Rabbani, Andrew Weston, Antonysunil Adaikalakoteswari, Justin A. Lee, Leif E. Lovblom, Nancy Cardinez, Paul J. Thornalley
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
R
Q
Acceso en línea:https://doaj.org/article/47281097893340babbde4bad245dd376
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:47281097893340babbde4bad245dd376
record_format dspace
spelling oai:doaj.org-article:47281097893340babbde4bad245dd3762021-12-02T16:06:39ZHigh fractional excretion of glycation adducts is associated with subsequent early decline in renal function in type 1 diabetes10.1038/s41598-020-69350-y2045-2322https://doaj.org/article/47281097893340babbde4bad245dd3762020-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-69350-yhttps://doaj.org/toc/2045-2322Abstract Increased protein glycation, oxidation and nitration is linked to the development of diabetic nephropathy. We reported levels of serum protein glycation, oxidation and nitration and related hydrolysis products, glycation, oxidation and nitration free adducts in patients with type 1 diabetes (T1DM) during onset of microalbuminuria (MA) from the First Joslin Kidney Study, a prospective case–control study of patients with T1DM with and without early decline in GFR. Herein we report urinary excretion of the latter analytes and related fractional excretion values, exploring the link to MA and early decline in GFR. We recruited patients with T1DM and normoalbuminuria (NA) (n = 30) or new onset MA with and without early GFR decline (n = 22 and 33, respectively) for this study. We determined urinary protein glycation, oxidation and nitration free adducts by stable isotopic dilution analysis liquid chromatography-tandem mass spectrometry (LC–MS/MS) and deduced fractional excretion using reported plasma levels and urinary and plasma creatinine estimates. We found urinary excretion of pentosidine was increased ca. twofold in patients with MA, compared to normoalbuminuria (0.0442 vs 0.0103 nmol/mg creatinine, P < 0.0001), and increased ca. threefold in patients with early decline in GFR, compared to patients with stable GFR (0.0561 vs 0.0176 nmol/mg creatinine, P < 0.01). Urinary excretion of all other analytes was unchanged between the study groups. Remarkably, fractional excretions of 6 lysine and arginine-derived glycation free adducts were higher in patients with early decline in GFR, compared to those with stable GFR. Impaired tubular reuptake of glycation free adducts by lysine and arginine transporter proteins in patients with early GFR decline is likely involved. We conclude that higher fractional excretions of glycation adducts are potential biomarkers for early GFR decline in T1DM and MA. Measurement of these analytes could provide the basis for identifying patients at risk of early decline in renal function to target and intensify renoprotective treatment.Bruce A. PerkinsNaila RabbaniAndrew WestonAntonysunil AdaikalakoteswariJustin A. LeeLeif E. LovblomNancy CardinezPaul J. ThornalleyNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Bruce A. Perkins
Naila Rabbani
Andrew Weston
Antonysunil Adaikalakoteswari
Justin A. Lee
Leif E. Lovblom
Nancy Cardinez
Paul J. Thornalley
High fractional excretion of glycation adducts is associated with subsequent early decline in renal function in type 1 diabetes
description Abstract Increased protein glycation, oxidation and nitration is linked to the development of diabetic nephropathy. We reported levels of serum protein glycation, oxidation and nitration and related hydrolysis products, glycation, oxidation and nitration free adducts in patients with type 1 diabetes (T1DM) during onset of microalbuminuria (MA) from the First Joslin Kidney Study, a prospective case–control study of patients with T1DM with and without early decline in GFR. Herein we report urinary excretion of the latter analytes and related fractional excretion values, exploring the link to MA and early decline in GFR. We recruited patients with T1DM and normoalbuminuria (NA) (n = 30) or new onset MA with and without early GFR decline (n = 22 and 33, respectively) for this study. We determined urinary protein glycation, oxidation and nitration free adducts by stable isotopic dilution analysis liquid chromatography-tandem mass spectrometry (LC–MS/MS) and deduced fractional excretion using reported plasma levels and urinary and plasma creatinine estimates. We found urinary excretion of pentosidine was increased ca. twofold in patients with MA, compared to normoalbuminuria (0.0442 vs 0.0103 nmol/mg creatinine, P < 0.0001), and increased ca. threefold in patients with early decline in GFR, compared to patients with stable GFR (0.0561 vs 0.0176 nmol/mg creatinine, P < 0.01). Urinary excretion of all other analytes was unchanged between the study groups. Remarkably, fractional excretions of 6 lysine and arginine-derived glycation free adducts were higher in patients with early decline in GFR, compared to those with stable GFR. Impaired tubular reuptake of glycation free adducts by lysine and arginine transporter proteins in patients with early GFR decline is likely involved. We conclude that higher fractional excretions of glycation adducts are potential biomarkers for early GFR decline in T1DM and MA. Measurement of these analytes could provide the basis for identifying patients at risk of early decline in renal function to target and intensify renoprotective treatment.
format article
author Bruce A. Perkins
Naila Rabbani
Andrew Weston
Antonysunil Adaikalakoteswari
Justin A. Lee
Leif E. Lovblom
Nancy Cardinez
Paul J. Thornalley
author_facet Bruce A. Perkins
Naila Rabbani
Andrew Weston
Antonysunil Adaikalakoteswari
Justin A. Lee
Leif E. Lovblom
Nancy Cardinez
Paul J. Thornalley
author_sort Bruce A. Perkins
title High fractional excretion of glycation adducts is associated with subsequent early decline in renal function in type 1 diabetes
title_short High fractional excretion of glycation adducts is associated with subsequent early decline in renal function in type 1 diabetes
title_full High fractional excretion of glycation adducts is associated with subsequent early decline in renal function in type 1 diabetes
title_fullStr High fractional excretion of glycation adducts is associated with subsequent early decline in renal function in type 1 diabetes
title_full_unstemmed High fractional excretion of glycation adducts is associated with subsequent early decline in renal function in type 1 diabetes
title_sort high fractional excretion of glycation adducts is associated with subsequent early decline in renal function in type 1 diabetes
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/47281097893340babbde4bad245dd376
work_keys_str_mv AT bruceaperkins highfractionalexcretionofglycationadductsisassociatedwithsubsequentearlydeclineinrenalfunctionintype1diabetes
AT nailarabbani highfractionalexcretionofglycationadductsisassociatedwithsubsequentearlydeclineinrenalfunctionintype1diabetes
AT andrewweston highfractionalexcretionofglycationadductsisassociatedwithsubsequentearlydeclineinrenalfunctionintype1diabetes
AT antonysuniladaikalakoteswari highfractionalexcretionofglycationadductsisassociatedwithsubsequentearlydeclineinrenalfunctionintype1diabetes
AT justinalee highfractionalexcretionofglycationadductsisassociatedwithsubsequentearlydeclineinrenalfunctionintype1diabetes
AT leifelovblom highfractionalexcretionofglycationadductsisassociatedwithsubsequentearlydeclineinrenalfunctionintype1diabetes
AT nancycardinez highfractionalexcretionofglycationadductsisassociatedwithsubsequentearlydeclineinrenalfunctionintype1diabetes
AT pauljthornalley highfractionalexcretionofglycationadductsisassociatedwithsubsequentearlydeclineinrenalfunctionintype1diabetes
_version_ 1718384900314234880